Latest News
CARBOGEN AMCIS Announces Successful Refinancing and Enhancement of their Syndicated Credit Facilities to Support Continued Growth and Investment
CARBOGEN AMCIS Announces Successful Refinancing and Enhancement of their Syndicated Credit Facilities to Support Continued Growth and Investment
Celonic Group and CARBOGEN AMCIS Announce Strategic Alliance to Deliver Fully Integrated ADC Development and Manufacturing Platform
Celonic Group and CARBOGEN AMCIS Announce Strategic Alliance to Deliver Fully Integrated ADC Development and Manufacturing Platform
CARBOGEN AMCIS Accelerates Manufacturing Capacity with CHF 25.5 Million Co-Investment at Swiss Sites
BUBENDORF, Switzerland – (04 June 2025) – CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce a strategic co-investment of more than CHF 25 million with a long-standing Japanese customer to expand manufacturing capabilities at its sites in Aarau and Neuland, Switzerland.
CARBOGEN AMCIS Shanghai Site Awarded Drug Manufacturing License from Chinese NMPA
BUBENDORF, Switzerland – (22d April 2025) – CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company is pleased to announce that its Shanghai facility has successfully obtained its first Drug Manufacturing License (DML) from China’s National Medical Products Administration (NMPA).
CARBOGEN AMCIS Secures GMP Certification After Successful ANSM Inspection for its Aseptic Drug Product Manufacturing Site
Bubendorf, Switzerland (March 24, 2025) – Switzerland-based CARBOGEN AMCIS, a leading phar-maceutical process development and Active Pharmaceutical Ingredient (API) manufacturing com-pany, is pleased to announce the successful completion of the first inspection by the French
regulatory authority, ANSM (Agence nationale de sécurité du médicament et des produits de san-té), at its state-of-the-art sterile drug product manufacturing site in Saint-Beauzire, France.
CARBOGEN AMCIS Announces Leadership Transition
BUBENDORF, Switzerland (February 3, 2025) — Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, has announced the departure of its current CEO, Pascal Villemagne as of March 31 and the appointment of his replacement, Stephan Fritschi.
Swissmedic Inspection Success Highlights Excellence at CARBOGEN AMCIS Vionnaz Site
BUBENDORF, Switzerland (January 13, 2025) — Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce the successful completion of a Swissmedic inspection of its Vionnaz facility, reaffirming the site’s compliance with high regulatory standards.
CARBOGEN AMCIS Announces Two Successful FDA Inspections at Its Manufacturing Sites in Neuland and Aarau, Switzerland
BUBENDORF, Switzerland (July 22, 2024) —Switzerland-based CARBOGEN AMCIS, a leading pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce the successful completion of U.S. Food and Drug Administration (FDA) inspections at its Neuland and Aarau sites.
CARBOGEN AMCIS announces successful ANVISA audit of its facility in China
BUBENDORF, Switzerland (19 March 2024) – Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announces the successful completion of its first Brazilian Regulatory Authority Agency (ANVISA) routine inspection of its facility in Shanghai.
CARBOGEN AMCIS Manchester wins prestigious Chemical Industry Award for world-class manufacturing performance
Manchester, UK (20 June 2023) – CARBOGEN AMCIS Manchester, a member of the Switzerland-based CARBOGEN AMCIS Group, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, won the Manufacturing and Resource Efficiency Award at the prestigious Chemistry Industry Awards last week.
Upcoming Events
Search
DCAT Week 2026
InterContinental New York Barclay, New York City
Converted Room #723, Converted Room 554
